Long-term results of Berlin-Frankfurt-Muenster based therapy for childhood and adolescents’ lymphoblastic lymphoma

QR Code

Long-term results of Berlin-Frankfurt-Muenster based therapy for childhood and adolescents’ lymphoblastic lymphoma

Lymphoblastic lymphoma (LBL) is one of predominant childhood non-Hodgkin’s lymphoma (NHL) subtypes and consists 25—30 %. The study purpose was to investigate outcomes in children and adolescents with LBL treated with protocol NHL-BFM-90 and 95 in the Moscow region. 58 primary patients (m–40, f–1...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. S. Kulikova, S. V. Semochkin, D. V. Litvinov, E. V. Inuschkina, N. V. Myakova, K. L. Kondratchik, L. V. Baidun, D. M. Konovalov, D. A. Peregudov, L. N. Schelichova, E. V. Samochatova
Format:	Article
Language:	Russian
Published:	ABV-press 2022-11-01
Series:	Онкогематология
Subjects:	lymphoblastic lymphoma children adolescents therapy nhl-bfm-90 and 95 protocols
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/700
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and social efficiency of therapy of acute lymphoblastic leukemia among children from 1993 to 2011 in Omsk Region
by: N. N. Kotskaya, et al.
Published: (2012-12-01)

Comparative analysis of three various chemotherapy protocols for acute lymphoblastic leukemia BFM-90m, MB-91 and PECO-92 in Moscow and St.-Petersburg
by: E. G. Boichenko, et al.
Published: (2022-11-01)

Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
by: T. T. Valiev, et al.
Published: (2022-07-01)

Changes in the Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia—Single Center, Real-Life Experience
by: Letitia E. Radu, et al.
Published: (2025-06-01)

Achieving the fast track 90-90-90 and 95-95-95 targets in sub-Saharan Africa: A rapid review
by: Celenkosini T. Nxumalo, et al.
Published: (2025-04-01)

Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol
by: M. A. Shervashidze, et al.
Published: (2024-12-01)

Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
by: J. V. Roumiantseva, et al.
Published: (2022-11-01)

Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”
by: M. O. Bagova, et al.
Published: (2021-09-01)

STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Actual questions of endoscopic diagnostic of non-Hodgkin lymphoma of stomach
by: O. A. Malikhova, et al.
Published: (2022-11-01)

FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Comparative analysis of therapy results in children with acute lymphoblastic leukemia receiving ALL-MB-2002 and COALL-St.Petersburg-92 protocols
by: E. G. Boychenko, et al.
Published: (2022-11-01)

HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
by: I. A. Demina, et al.
Published: (2018-02-01)

Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
by: I. A. Demina, et al.
Published: (2017-04-01)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Possibilities of rehabilitation treatment of children with lymphoblastic leukemia (literary review)
by: S.V. Lukashchuk, et al.
Published: (2021-12-01)

COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01)

Hemostasis defects correction in children with acute lymphoblastic leukemia
by: A. S. Roshik, et al.
Published: (2022-11-01)

Features of children temperament with acute lymphoblastic leukemia
by: N. A. Kornetov, et al.
Published: (2016-02-01)

Detection of 11q23 (MLL) rearrangements in infant acute lymphoblastic leukemia
by: G. A. Tsaur, et al.
Published: (2014-07-01)

Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
by: O. A. Aleshina, et al.
Published: (2023-03-01)

Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01)

FUNCTIONAL ACTIVITY OF NEUTROPHILS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: T. G. Kadricheva, et al.
Published: (2014-07-01)

Results of external quality control study in flow cytometric acute lymphoblastic leukemia diagnostics
by: A. M. Popov, et al.
Published: (2016-10-01)

Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features
by: O. D. Gurieva, et al.
Published: (2025-05-01)

RUSSIAN-BELARUSIAN MULTICENTER GROUP STANDARD GUIDELINES FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA FLOW CYTOMETRIC DIAGNOSTICS
by: I. A. Novikova, et al.
Published: (2018-05-01)

Clinical case of successful treatment of COVID-19 infection manifested with B-cell acute lymphoblastic leukemia
by: T. N. Aleksandrova, et al.
Published: (2022-01-01)

Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia
by: T. T. Valiev, et al.
Published: (2024-04-01)

IMMUNE PROFILE AND ENZYMES ACTIVITY STATE IN BLOOD LYMPHOCYTES IN PATIENTS OF DIFFERENT STAGES ACUTE LYMPHOBLAST LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Comparative efficacy of acute lymphoblastic leukemia treatment of children in St.-Petersburg using two COALL-92 versions
by: E. G. Boychenko, et al.
Published: (2014-07-01)

Complex rehabilitation of children with long-term acute lymphoblastic leukemia remission
by: I. V. Tkachenko, et al.
Published: (2022-11-01)

Study of Some Biochemical Parameters in Iraqi Children with Acute Lymphoblastic Leukemia
by: Baghdad Science Journal
Published: (2015-06-01)

Algorithm of Hepatitis B Vaccinal Prevention at Children with Acute Lymphoblastic Leukemia in Dynamics of Program Therapy
by: N. V. Opaleva, et al.
Published: (2010-06-01)

Pharmacoeconomic analysis of treatment of children with acute lymphoblastic leukemia according to ALL-MB-2002 protocol
by: N. V. Miga, et al.
Published: (2022-11-01)

Antileukemic impact of glucocorticoid use in acute lymphoblastic leukaemia treatment
by: Meri A. Shervashidze, et al.
Published: (2023-08-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
by: A. M. Popov, et al.
Published: (2015-12-01)

Molecular genetic abnormalities in patients with T-cell acute lymphoblastic leukemia: a literature review
by: A. N. Vasileva, et al.
Published: (2022-11-01)

Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01)

IKZF1 DELETIONS ARE INDEPENDENT PROGNOSTIC FACTOR IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
by: G. A. Tsaur, et al.
Published: (2017-01-01)